Kezar Life Sciences has paused its Phase IIb PALIZADE trial for zetomipzomib in lupus nephritis after four patient deaths, ...

US healthcare giant Johnson & Johnson (NYSE: JNJ) revealed it is discontinuing the Phase II field study (NCT05201794) ...

US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country ...

The Irish Healthcare Association (IPHA), the representative body for the research-based biopharmaceutical industry in ...

ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of ...

India's new Biotechnology Research Innovation and Entrepreneurship Development (Bio-RIDE) scheme is a significant step ...

Important regulatory news last week included French pharma major Sanofi gaining approval from the US Food and Drug ...

Mpox has proven to be a major public threat since its resurgence globally during the COVID years. On August 14, the World ...

Spain is moving forward with a framework for medical cannabis usage after delays due to a general election. The draft ...

UK-based biotech Resolution Therapeutics has raised £63.5 million ($76.8 million) in a series B round led by Syncona to ...

Opioid Use Disorder (OUD) is a chronic neurological disorder that is described as the consequences associated with repeated, ...

Trevi Therapeutics has achieved key milestones in its clinical programs for Haduvio (nalbuphine), a treatment targeting ...